TAI •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/24/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTAI
Market Capitalization5,497.4 mln
Float71.99 mln
EPS
0.90
Stretched
P / E
57.78
Richly valued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.66
Likely reliable
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.18
Very low leverage
Business Description
Founded in 1987 and headquartered in Taoyuan City, Taiwan, SCI Pharmtech develops, manufactures, and sells the active chemical components that go into finished medicines, along with related chemical building blocks used in drug production. The company serves customers across North America, Europe, Asia, and beyond, offering both standard product lines and custom manufacturing to meet specific client needs.
